T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
2651
DELISTED
Verve Therapeutics
VERV
| $195K | ﹤0.01% |
40,114
+10,800
| +37% | +$62.7K |
|
2652
Smith & Wesson
SWBI
$643M
| $193K | ﹤0.01% |
14,792
+393
| +3% | +$5.67K |
|
|
HTBK
2653
DELISTED
Heritage Commerce
HTBK
| $192K | ﹤0.01% |
19,366
+502
| +3% | +$4.9K |
|
2654
Motorcar Parts of America
MPAA
$235M
| $192K | ﹤0.01% |
25,900
| – | – |
|
|
STKL
2655
DELISTED
SunOpta
STKL
| $192K | ﹤0.01% |
30,091
+824
| +3% | +$4.83K |
|
2656
DocGo
DCGO
$64.5M
| $190K | ﹤0.01% |
57,028
| – | – |
|
2657
Genie Energy
GNE
$386M
| $189K | ﹤0.01% |
11,582
| – | – |
|
|
MRSN
2658
DELISTED
Mersana Therapeutics
MRSN
| $188K | ﹤0.01% |
3,963
| – | – |
|
2659
Ribbon Communications
RBBN
$377M
| $188K | ﹤0.01% |
57,626
+574
| +1% | +$1.86K |
|
2660
Titan Machinery
TITN
$420M
| $188K | ﹤0.01% |
13,458
| – | – |
|
2661
Westwood Holdings Group
WHG
$184M
| $188K | ﹤0.01% |
13,200
| – | – |
|
2662
Alphatec Holdings
ATEC
$1.51B
| $187K | ﹤0.01% |
33,542
+884
| +3% | +$6.79K |
|
2663
Mission Produce
AVO
$1.15B
| $187K | ﹤0.01% |
14,573
+256
| +2% | +$2.84K |
|
2664
Liquidia Corp
LQDA
$6.45B
| $187K | ﹤0.01% |
18,678
+321
| +2% | +$3.51K |
|
2665
Vipshop
VIPS
$6.8B
| $186K | ﹤0.01% |
11,800
-4,454
| -27% | -$59.6K |
|
2666
Arbutus Biopharma
ABUS
$906M
| $185K | ﹤0.01% |
47,804
+3,278
| +7% | +$12.6K |
|
|
FSP
2667
Franklin Street Properties
FSP
$46.4M
| $185K | ﹤0.01% |
104,257
| – | – |
|
|
SEMR
2668
DELISTED
Semrush
SEMR
| $185K | ﹤0.01% |
11,771
-46,677
| -80% | -$652K |
|
2669
Biomea Fusion
BMEA
$92.8M
| $184K | ﹤0.01% |
18,137
+3,600
| +25% | +$23.4K |
|
2670
Lexicon Pharmaceuticals
LXRX
$1.04B
| $184K | ﹤0.01% |
117,179
| – | – |
|
|
EARN
2671
Ellington Residential Mortgage REIT
EARN
$167M
| $183K | ﹤0.01% |
26,098
-1,480
| -5% | -$10.3K |
|
2672
KVH Industries
KVHI
$143M
| $183K | ﹤0.01% |
37,763
| – | – |
|
2673
NextNav
NN
$3.29B
| $183K | ﹤0.01% |
24,323
+415
| +2% | +$3.2K |
|
2674
XBiotech
XBIT
$71M
| $183K | ﹤0.01% |
23,625
| – | – |
|
2675
ARKO Corp
ARKO
$505M
| $182K | ﹤0.01% |
25,876
+621
| +2% | +$3.92K |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.